> ## Documentation index
> Fetch the complete documentation index at: [llms.txt](../llms.txt)
> Use this file to discover all available pages before exploring further.

# China coverage

How Sleuth covers Chinese programs, and how they show up next to everyone else's.

[See China data](https://www.sleuthinsights.com/china)

Sleuth covers over 22,000 Chinese programs, as of November 2026, from China's own registries, regulators, exchanges, journals, company posts, and broker research.

## The Chinese sources

- **Trial registries:** ChiCTR, the CDE drug trial registration platform, and ITMCTR.
- **Regulators:** NMPA approvals and CDE application, clearance, and priority review lists.
- **Exchanges:** HKEXnews, including 18A biotech prospectuses, and CNInfo.
- **Literature:** Chinese-language journals, theses, and conference papers.
- **Patents:** China National Intellectual Property Administration filings.
- **Company posts:** WeChat official accounts of Chinese biotechs and industry media, where pipeline news often appears first.
- **Pricing and statistics:** the National Reimbursement Drug List, China CDC, and the National Cancer Center.

## How it shows up

Sleuth translates each source and runs it through the same matching and checks as every other source. A Chinese company's program appears in the same table as a US one, under the same drug record, and companies carry both their Chinese and English names. Search in English; you don't need to know the Chinese name.

## Related

- [Every source](sources.md): The registries, regulators, journals, filings, and feeds Sleuth reads, grouped by what they answer.
- [What's in the knowledge base](knowledge-base.md): The records Sleuth works from, how many there are, and how they connect.
- [Explore the knowledge base](explore.md): Filter the records Sleuth works from and build your own dataset, with no credits.

*Updated November 9, 2026.*
